Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOVIPREP versus Citrafleet for polyp detection during colonoscopy
2011-002364-25Phase 4Completed
- Sponsor
- Norgine
- Start
- Aug 2011
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing MOVIPREP with Citrafleet (2 arms). Primary endpoint: Polyp detection rate. Started Aug 2011; status: completed.
02
Drugs
macrogolsodium picosulfate
Beyond the preview
Go deeper on 2011-002364-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002364-25.